LIVN
LivaNova Plc
NASDAQ · Healthcare · Medical - Devices · GB
$80.90
−0.46%Price chart
Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20Oct 23
Key dataOct 23, 2026
Open$81.01
From 52W high−5.19%
Volume572060.00
Market cap$4.46B
P/E (TTM)23.4x
P/S (TTM)3.0x
Div yield—
Key dataOct 23, 2026
Open
$81.01
From 52W high
−5.19%
Volume
572060.00
Market cap
$4.46B
ValuationView details →
P/E (Fwd)
17.9x
EV/EBITDA
19.8x
P/E (TTM)
23.4x
RSI (14)
60.9
MomentumView details →
1D Return
−0.46%
YTD Return
+31.78%
SummaryUpdated Jun 1, 2026
LivaNova PLC (NASDAQ:LIVN) is a medical device company founded in 1987 and headquartered in London, United Kingdom. The company was created through the 2015 merger of Cyberonics and Sorin Group, combining expertise in neuromodulation and cardiac surgery technologies. LivaNova designs, develops, manufactures, and sells therapeutic solutions globally, focusing on three core segments: cardiopulmonary products for heart surgery, neuromodulation devices for neurological conditions, and advanced circulatory support systems. The company serves hospitals, medical institutions, and healthcare providers worldwide through direct sales representatives and independent distributors.
Similar companies
Latest newsMore news →
LivaNova announced publication of the full 36-month LivaNova PLC results evaluating its VNS Therapy devices in people with drug-resistant epilepsy.2d agoLivaNova PLC reported its second-quarter 2026 financial results, with revenue of $390.6 million, up 10.8% on a reported basis and 9.8% on a constant-currency basis year-over-year, and U.S. GAAP diluted EPS of $1.93.81d ago